| ²é¿´: 5618 | »Ø¸´: 72 | |||||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û63´Î£¬×÷Õßzfyzfy070707Ôö¼Ó½ð±Ò 49.2 ¸ö | |||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||||
[×ÊÔ´]
FDA¹ØÓÚBCS I ºÍIIIÀàËÙÊÍÖÆ¼ÁÈܳöʵÑéºÍ¿É½ÓÊܱê×¼Ö¸µ¼ÔÔò²Ý°¸
|
|||||
|
FDA¹ØÓÚBCS I ºÍIIIÀàËÙÊÍÖÆ¼ÁÈܳöʵÑéºÍ¿É½ÓÊܱê×¼Ö¸µ¼ÔÔò²Ý°¸ ÈܳöʵÑéÌõ¼þÈçÈܳö×°ÖúÍתËÙ£¬½éÖÊ¡£ ¿É½ÓÊܱê×¼ |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : FDA_guideline__BCS_I_and_BCS_III_dissolution__test_and_specification.pdf
2015-12-28 19:21:26, 87.43 K
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
Ò©ÎïÑз¢ÖªÊ¶ | ´ýÏÂÔØ | ziliao |
» ²ÂÄãϲ»¶
288·ÖÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
349ҩѧר˶105500Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ87È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ1È˻ظ´
298Çóµ÷¼ÁÒ»Ö¾Ô¸Öк£Ñó
ÒѾÓÐ3È˻ظ´
ҩѧµ÷¼ÁÉêÇë×Ô¼öÐÅ£¬Ò»Ö¾Ô¸ÖÐÄÏ´óѧ
ÒѾÓÐ1È˻ظ´
ҩѧ349ר˶Çóµ÷¼Á
ÒѾÓÐ1È˻ظ´
Ò»Ö¾Ô¸ËÕÖÝ´óѧ ÉúÎï¼¼ÊõÓ빤³Ì£¨086001£© ³õÊÔ323·Ö£¬Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ÈýÄêʵÑéÊÒ¹¤×÷¾Àú£¬Ò»Ö¾Ô¸»ªÖÐũҵ´óѧ΢ÉúÎ×Ü·Ö288Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
¡¶×óÒÒÀÎ÷̹עÉäÒºÖÆ±¸¹¤ÒÕÑо¿¡¢ÖÊÁ¿¿ØÖƺÍÎȶ¨ÐÔÑо¿¡·ÏÂÔØ
ÒѾÓÐ1È˻ظ´
46Â¥2016-01-12 11:16:20
¶ú¶ä
ľ³æ (ÕýʽдÊÖ)
- DRDEPI: 1
- Ó¦Öú: 85 (³õÖÐÉú)
- ½ð±Ò: 4300.1
- Ìû×Ó: 428
- ÔÚÏß: 169.8Сʱ
- ³æºÅ: 1193088
12Â¥2015-12-29 13:43:44
¼òµ¥»Ø¸´
work0372Â¥
2015-12-28 22:31
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
xxxx198803053Â¥
2015-12-29 08:29
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
xxxx198803054Â¥
2015-12-29 08:31
»Ø¸´
¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
ºì²Ý5Â¥
2015-12-29 08:38
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
xibeifeng016Â¥
2015-12-29 08:42
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
wdl7Â¥
2015-12-29 08:47
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
cheugy98Â¥
2015-12-29 09:09
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
Äýˮʯ9Â¥
2015-12-29 10:02
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
sunmh200310Â¥
2015-12-29 10:44
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
linglingF811Â¥
2015-12-29 13:41
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
wltsm14Â¥
2015-12-29 14:34
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡













»Ø¸´´ËÂ¥